Örebro University
Örebro, Sweden
NCT Number: NCT06309004
The goal of this clinical trial is to develop and test the iACTforDGBI intervention in a sample of Swedish individuals with DGBI (Disorders of Gut-Brain Interaction).
The first substudy of this project (Substudy 1) aims to answer the following question: How can the design of iACTforDGBI be tailored to meet the specific needs of individuals with DGBI and clinically meaningful symptoms of anxiety and depression?
Participants (individuals with symptoms compatible with a DGBI and anxiety and/or depression, and healthcare professionals working with DGBI patients) will be asked to participate in online focus-group interviews and provide information on their views of a preliminary version of the iACTforDGBi intervention.
This study is active but is not currently recruiting participants.
18 year–75 year
All sexes
Observational
Örebro, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
DGBI participants:
Inclusion criteria
Exclusion criteria
Healthcare professionals:
Inclusion criteria
a) Being a healthcare professional currently working with DGBI patients and/or with ACT-based/digital interventions.
Time frame: 60-90 minutes per interview
Focus group interviews
Örebro University, Sweden
Other
Development, Feasibility, Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (Sub-study 1)
Acronym: iACTforDGBI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07246239
Anxiety Disorders, Anxiety and Depression
Barcelona, Spain
View Trial DetailsNCT06188923
Anxiety Disorders, Anxiety and Depression
Durham, North Carolina, United States
View Trial DetailsNCT06853587
Anxiety Disorders, Anxiety and Depression
Calgary, Alberta, Canada
View Trial DetailsNCT07292155
Anxiety Disorders, Anxiety and Depression
Yozgat, Turkey (Türkiye)
View Trial Details